Finally, Salonia et al. stratified patients with COVID-19 according to different types of hypogonadism: total testosterone and LH levels were suggestive of secondary hypogonadism in 85% of the patients analyzed [10]. The gene discussed is PLOD1; the disease is hypogonadism.